General Information
Axsome MDD 301
A Randomized, Double-Blind, Placebo-Controlled Trial of Solriamfetol in Subjects with Major Depressive Disorder
| Protocol | SOL-MDD-301 |
|---|---|
| Identifier | |
| UID | 70abea4d-0cbd-41f6-9f2b-0d8ca0629530 |
| Status | Done - Archived |
| Phase | 3 |
| Category | Major Depressive Disorder / Adult |
| Launch Year | 2024 |
| NCT Number | - |
| Created | 2024-05-01 13:20 |
| Last Updated | 2025-09-10 16:22 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2024-10-11 | No |
| Enrollment Open | 2024-07-08 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2024-06-26 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2025-05-21 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Volk, Stephen | SVolk | No |
| Recruiter | Gomez, Kathie | KGomez | No |
| Coordinator | Sandoval, Larry | LSandoval | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Axsome Therapeutics |
|---|---|
| Division | Axsome Therapeutics |
| Team | Axsome Therapeutics |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
